Advertisement
Advertisement
U.S. Markets open in 1 hr 51 mins
Advertisement
Advertisement
Advertisement
Advertisement

Sona Nanotech Inc. (SNANF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.30900.0000 (0.00%)
At close: 03:49PM EST
Advertisement

Sona Nanotech Inc.

Purdy’s Wharf Tower II
Suite 2001 1969 Upper Water Street
Halifax, NS B3J 3R7
Canada
902 442 0653
https://www.sonanano.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. David A. ReganChief Exec. Officer164.24kN/AN/A
Mr. Darren RowlesPres & Chief Scientific Officer132.62kN/A1979
Mr. Robert William George RandallCFO & Corp. Sec.87.4kN/A1963
Dr. Kulbir SinghCo-Founder & Head of R&DN/AN/AN/A
Dr. Mike McAlduffDirector of R&D & Production and FounderN/AN/AN/A
Dr. Gerrard MarangoniCo-Founder & Member of Scientific Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sona Nanotech Inc., nanotechnology life sciences company, manufactures gold nanorod products for diagnostic tests. Its products portfolio comprises Gemini 650NM, Gemini 700NM, Gemini 725NM, Gemini 750NM, Gemini 800NM, Gemini 850NM, Gemini 900NM, Gemini 950NM, and Gemini 1050NM. The company also provides Sona Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens from individuals, who are suspected of COVID-19. In addition, it offers Gemini and Omni gold nanorods for in-vitro and in-vivo applications, such as lateral flow diagnostics and cell imaging. The company has collaboration agreements with Soma Bioscience Ltd. to produce diagnostic tests using lateral flow assay technology; and Expedeon Ltd to develop multiplex point-of-care and lateral flow assay diagnostic tests. Sona Nanotech Inc. is based in Halifax, Canada.

Corporate Governance

Sona Nanotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement